Fairvalue-Calculator Fairvalue-Calculator
EN DE

ImpediMed Limited (IPDQF) Fair Value & Analysis

Healthcare · US · Market cap $13.8M

Price$0.0077
Fair Value$0.0079
Upside+2.3%
Quality95/100
Evidence: Low

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ImpediMed Limited (IPDQF) currently trades at $0.0077, while our model-based Fair Value estimate is $0.0079 — implying the stock looks roughly 2.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is ImpediMed Limited (IPDQF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0079 versus a price of $0.0077 — about +2% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IPDQF?
Our 21-model fair value for ImpediMed Limited is $0.0079 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0077.
What is the quality score of IPDQF?
ImpediMed Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.